Are AstraZeneca preparing to purchase spl, page-72

Yes @antibotter ... with a comment like this at the bottom of the article, I would start to get a little worried if AstraZeneca don't even mention AZD0466 at this conference ? If AZD0466 is not mentioned IMO it would 'appear' on the surface that it is not a big priority for AstraZeneca at present?? If they do speak about it then happy days for SPL


José Baselga, Executive Vice President, Research & Development, Oncology, said: “We will be sharing some of our latest research at the 2019 AACR Annual Meeting, including 28 new molecular entities and six combinations, highlighting an exciting new phase of scientific discovery from our Oncology R&D.”